Amundi Scholar Rock Holding Corp Transaction History
Amundi
- $275 Billion
- Q4 2024
A detailed history of Amundi transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Amundi holds 23 shares of SRRK stock, worth $932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$932% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRRK
# of Institutions
192Shares Held
74.3MCall Options Held
589KPut Options Held
866K-
Siren, L.L.C. New York, NY11.3MShares$456 Million4.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.65MShares$351 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$275 Million31.52% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$230 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.24MShares$212 Million2.74% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $2.09B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...